Unknown OBSERVATIONAL NCT05085093

Protective Efficacy of HPV Vaccination After Treatment of HPV Related Diseases

Sponsor: Xijing Hospital

Conditions HPV Vaccination、HPV Related Diseases、Protective Efficacy

Interventions HPV vaccine

Updated 4 times since 2021 Last updated: Oct 19, 2021 Started: Sep 18, 2021 Primary completion: Mar 1, 2022 Completion: Sep 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates HPV Vaccination、HPV Related Diseases、Protective Efficacy and is currently ongoing. Xijing Hospital leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Oct 2024 — Present [monthly]

Unknown

Status: Enrolling By Invitation → Unknown
Sep 2024 — Oct 2024 [monthly]

Enrolling By Invitation
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation
Nov 2021 — Jul 2024 [monthly]

Enrolling By Invitation

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xijing Hospital

Data source: Xijing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China